中國海防(600764.SH):國風投基金及其一致行動人擬合計減持不超2%股份
格隆匯5月13日丨中國海防(600764.SH)公佈,國風投基金及其一致行動人國新投資計劃以集中競價、大宗交易方式減持其所持有的不超過14,212,587股公司股份,減持比例不超過公司總股本的2.00%,減持期間為本減持計劃披露之日起15個交易日後的3個月內。採用集中競價交易方式的,在任意連續90日內,合計減持股份的總數不超過公司股份總數的1%,即不超過7,106,293股;採用大宗交易方式的,在任意連續90日內,合計減持股份的總數不超過公司股份總數的2%,即不超過14,212,587股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.